Callan Family Office’s HilleVax HLVX Stock Holding History

Callan Family Office’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,734	Closed	-$23.4K	–	898
2025 Q2	$23.4K	Sell	11,734 -7,593	-39%	-$13.9K	﹤0.01%	909
2025 Q1	$28K	Buy	+19,327	New	+$35.7K	﹤0.01%	543

Callan Family Office's HLVX Position: Q3 2025 in Review

Callan Family Office sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 11,734 shares — an estimated $23.4K sold.

Callan Family Office first reported a position in HLVX in Q1 2025 and held it in 2 quarters. The position peaked at $28K in Q1 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Callan Family Office reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Callan Family Office sold 11,734 HilleVax shares in Q3 2025, an estimated $23.4K.
Callan Family Office first reported a position in HilleVax in Q1 2025 and held it in 2 quarters.
Callan Family Office's HilleVax position peaked at $28K in Q1 2025.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Callan Family Office's 13F filing for Q3 2025, filed 4 Nov 2025.